--- title: "東建國際折讓 18.84% 配股 籌淨額 8,337 萬元" description: "東建國際公佈,配售最多 2.999 億股新股,相當於擴大後股本 16.67%;配售價 0.28 元,較上交易日 (11 日) 收報折讓 18.84%。集資總額 8,399 萬元,所得淨額 8,337 萬元,擬用於公司投資授權的投資;擴展葡萄酒及飲品業務;及一般營運資金。" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/248273402.md" published_at: "2025-07-13T05:17:40.000Z" --- # 東建國際折讓 18.84% 配股 籌淨額 8,337 萬元 > 東建國際公佈,配售最多 2.999 億股新股,相當於擴大後股本 16.67%;配售價 0.28 元,較上交易日 (11 日) 收報折讓 18.84%。集資總額 8,399 萬元,所得淨額 8,337 萬元,擬用於公司投資授權的投資;擴展葡萄酒及飲品業務;及一般營運資金。 東建國際 (00329.HK) 公佈,配售最多 2.999 億股新股,相當於擴大後股本 16.67%;配售價 0.28 元,較上交易日 (11 日) 收報折讓 18.84%。集資總額 8,399 萬元,所得淨額 8,337 萬元,擬用於公司投資授權的投資;擴展葡萄酒及飲品業務;及一般營運資金。 ### Related Stocks - [00329.HK - 東建國際](https://longbridge.com/zh-HK/quote/00329.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Tennis-Pegula fights back to beat Anisimova in Dubai semi-final | Jessica Pegula overcame a first-set loss to defeat Amanda Anisimova 1-6, 6-4, 6-3 in the Dubai Tennis Championships semi | [Link](https://longbridge.com/zh-HK/news/276467572.md) | | Yankuang Energy Wins HKEX Approval for Kasong Science and Technology Spin-Off | Yankuang Energy Wins HKEX Approval for Kasong Science and Technology Spin-Off | [Link](https://longbridge.com/zh-HK/news/276023181.md) | | Olympics-Curling-World champions Britain to play Canada for men's curling gold | World champions Britain defeated Switzerland 8-5 in the men's curling semi-finals at the Winter Olympics, setting up a f | [Link](https://longbridge.com/zh-HK/news/276382883.md) | | Olympics-Curling-South Korea's '5G' team braced for Canada test | South Korea's women's curling team, known as the '5G' team, faces a crucial match against top-ranked Canada in the Winte | [Link](https://longbridge.com/zh-HK/news/276256016.md) | | Natural rubber demand to exceed output, keeping prices high in 2026, says ANRPC | Global demand for natural rubber is expected to exceed production for the sixth consecutive year in 2026, driven by grow | [Link](https://longbridge.com/zh-HK/news/276309843.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。